サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1606433

クロノセラピーサービス市場：製品タイプ別、治療領域別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年

Chronotherapy Services Market, By Product Type, By Therapeutic Area, By End-user, By Country, and By Region -Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 260 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
クロノセラピーサービス市場：製品タイプ別、治療領域別、エンドユーザー別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024年～2032年
出版日: 2024年11月04日
発行: AnalystView Market Insights
ページ情報: 英文 260 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

クロノセラピーサービス市場規模は2023年に8億7,090万米ドルとなり、2024年から2032年にかけてCAGR 4.50%で拡大

クロノセラピーサービス市場- 市場力学

クロノセラピーは、気分障害の治療を最適化することで、メンタルヘルスを支援します。

クロノセラピーは、メンタルヘルス治療、特にうつ病、不安障害、季節性情動障害（SAD）のような気分障害の治療において人気を集めています。この成長の主な原動力は、概日リズムが精神衛生に果たす重要な役割に対する理解の高まりです。身体の自然な睡眠・覚醒サイクルの乱れが、気分の不均衡につながるケースが増えており、クロノセラピーは、治療のタイミングを体内時計に合わせることでこれに対処することができます。光治療の睡眠最適化技術や薬剤投与タイミングの進歩は、気分障害管理における有効性をさらに裏付けています。さらに、個別化された患者中心のケアモデルの採用が増加していることも重要な要因です。

また、クロノセラピーは、治療が行われるタイミングを最適化することで、薬の副作用を軽減し、治療成果を高めることができるという調査結果も出ています。米国国立精神衛生研究所（NIMH）は、概日リズムの乱れが精神疾患と強く関連していることを強調しており、この市場の可能性をさらに立証しています。カリフォルニア大学バークレー校などの大学では、気分調節における概日生物学の役割に関する研究を実施しており、クロノセラピーを効果的に実施する方法について貴重な知見を提供しています。

クロノセラピーサービス市場-主な洞察

調査アナリストの分析によると、世界市場は予測期間（2024-2032年）にCAGR約4.50%で年間成長すると推定されます。

製品タイプ別では、クロノセラピー薬が2023年に最大の市場シェアを示すと予測されます。

治療領域別では、2023年にオンコロジーが主要タイプに

エンドユーザー別では、2023年には病院＆クリニックが主要タイプでした。

地域別では、北米が2023年の売上高でトップ

クロノセラピーサービス市場-セグメンテーション分析：

クロノセラピーサービスの世界市場は、製品タイプ、治療領域、エンドユーザー、地域に基づいてセグメント化されます。

市場は製品タイプによって2つに分類される：クロノセラピーシステムとクロノセラピー医薬品です。クロノセラピーサービス市場では、クロノセラピー医薬品分野が最も顕著かつ重要です。これは主に、治療効果を高めるためのドラッグデリバリーにおけるタイミングの重要性が認識されつつあるためです。クロノセラピー医薬品は、身体の自然な概日リズムに同調して作用するように特別に設計されており、喘息、高血圧、がんなどの治療成績を向上させる。慢性疾患の有病率の増加と個別化医療への需要がクロノセラピー医薬品の採用を促進し、市場を独占しています。さらに、ドラッグ製剤やドラッグデリバリーシステムの進歩が、その存在感をさらに高めています。

市場は治療分野別に5つのカテゴリーに分類される：腫瘍学、神経学、心血管疾患、呼吸器疾患、その他です。クロノセラピーサービス市場では、がん領域が最も顕著かつ重要です。がん治療では、薬効を最適化し副作用を最小化するために正確なタイミングが必要とされることが多く、クロノセラピーは特に有用です。化学療法のタイミングを体の概日リズムに合わせることで、薬剤の効果を高め、患者の転帰を改善し、毒性を軽減することができます。世界のがん罹患率の増加とクロノセラピー研究の進歩により、腫瘍学は主要な治療分野となり、クロノセラピーサービス市場の成長の大部分を牽引しています。さらに、患者のコンプライアンスと治療成績が改善される可能性が、その優位性をさらに強めています。

クロノセラピーサービス市場-地理的洞察

クロノセラピーサービス市場の北米地域情勢は、特に睡眠障害、うつ病、高血圧などの慢性疾患の管理において、個別化医療への需要が高まっていることを特徴としています。概日リズムとその健康への影響に対する認識が高まるにつれ、クロノセラピーは臨床とウェルネスの両方の場面で支持を集めています。米国は、医療技術の進歩、高齢化、高いヘルスケア支出に牽引され、市場をリードしています。カナダも、特に研究・学術分野で成長を示しています。この地域の主なプレーヤーは、ウェアラブルデバイスやデジタルプラットフォームなど、治療タイミングを最適化するための革新的ソリューションの開発に注力しています。政府の規制、保険適用範囲、医療インフラは、市場力学の形成に重要な役割を果たしています。しかし、臨床検証や患者導入の必要性などの課題は依然として残っています。

クロノセラピーサービス市場-競合情勢：

クロノセラピーサービス市場の競合情勢は、大手製薬企業、バイオテクノロジー専門企業、概日リズムに基づく治療に注力する新興企業が混在して形成されています。ジョンソン・エンド・ジョンソン、ファイザー、ノバルティスなどの大手製薬会社は、クロノバイオロジーの研究に投資し、放出制御薬やクロノセラピーに特化したドラッグデリバリーシステムなど、特定の時間帯に最適化した治療を開発しています。サーカディアン・セラピューティクス（Circadian Therapeutics）のような小規模で革新的な企業は、個人に合わせたクロノセラピー・モデルを開発し、オーダーメイドの治療ソリューションを提供しています。この市場はまた、がん、精神疾患、睡眠関連疾患などの症状におけるクロノバイオロジーの新たな応用を探求する、ヘルスケアプロバイダー、大学、研究機関の共同研究によっても支えられています。競合戦略には、薬剤処方における技術的進歩、概日リズムをモニターするためのウェアラブルデバイスの使用、患者の転帰を向上させる精密医療の開発などが含まれます。治療を体内時計と同期させることの利点に対する意識の高まりが、今後の競争を促進すると予想されます。

目次

第1章 クロノセラピーサービス市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 クロノセラピーサービスの主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 クロノセラピーサービス産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 クロノセラピーサービス市場：高まる地政学的緊張の影響

  • COVID-19パンデミックの影響
  • ロシア・ウクライナ戦争の影響
  • 中東紛争の影響

第6章 クロノセラピーサービスの市場情勢

  • クロノセラピーサービス市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 クロノセラピーサービス市場-製品タイプ別

  • 概要
    • セグメントシェア分析
    • クロノセラピーシステム
    • クロノセラピー医薬品

第8章 クロノセラピーサービス市場- 治療領域別

  • 概要
    • セグメントシェア分析
    • 腫瘍学
    • 神経学
    • 心血管疾患
    • 呼吸器疾患
    • その他

第9章 クロノセラピーサービス市場- エンドユーザー別

  • 概要
    • セグメントシェア分析
    • 病院・クリニック
    • ホームケア設定
    • その他

第10章 クロノセラピーサービス市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋地域
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東およびアフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- クロノセラピーサービス業界

  • 競合ダッシュボード
    • Competitive Benchmarking
    • Competitive Positioning
  • 企業プロファイル
    • Johnson &Johnson
    • Novartis
    • Pfizer
    • Merck &Co.
    • Sanofi
    • Roche
    • GlaxoSmithKline
    • AbbVie
    • Bayer
    • Eli Lilly and Company
    • Amgen
    • AstraZeneca
    • Bristol-Myers Squibb
    • Gilead Sciences
    • Teva Pharmaceutical Industries
    • Medtronic
    • Zogenix
    • Circadian Therapeutics

第12章 アナリストの全方位的展望

目次
Product Code: ANV4258

REPORT HIGHLIGHT

Chronotherapy Services Market size was valued at USD 870.90 million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.

The chronotherapy services market refers to the industry focused on aligning medical treatments with an individual's natural biological rhythms, such as the circadian cycle. This approach involves timing interventions like medication administration, lifestyle changes, or therapy sessions based on optimal periods during the day when the body is most receptive to treatment. Chronotherapy aims to enhance the efficacy of treatments, minimize side effects, and improve patient outcomes. It is especially relevant in areas such as sleep disorders, cardiovascular health, cancer treatment, and mental health. As the understanding of the circadian rhythm grows, more healthcare providers are adopting chronotherapy to optimize care. The market is expected to grow as personalized medicine and precision therapies continue to advance. Key drivers include increasing awareness of chronobiology and innovations in drug delivery systems.

Chronotherapy Services Market- Market Dynamics

Chronotherapy aids mental health by optimizing treatment for mood disorders.

Chronotherapy is gaining traction in mental health treatment, particularly for mood disorders like depression, anxiety, and seasonal affective disorder (SAD). The primary driver for this growth is the growing understanding of the significant role circadian rhythms play in mental health. Disruptions in the body's natural sleep-wake cycles are increasingly linked to mood imbalances, which chronotherapy can address by aligning treatment timing with the body's biological clock. Advancements in light therapy sleep optimization techniques and drug administration timing further support its efficacy in mood disorder management. Furthermore, the rising adoption of personalized, patient-centric care models is a key factor.

Research is also showing that chronotherapy can reduce medication side effects and enhance therapeutic outcomes by optimizing when treatments are administered. The National Institute of Mental Health (NIMH) highlights that circadian rhythm disruptions are strongly associated with mental health disorders, further validating the market's potential. Universities, such as the University of California, Berkeley, are conducting studies on circadian biology's role in mood regulation, providing valuable insights into how chronotherapy can be implemented effectively.

Chronotherapy Services Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2024-2032)

Based on Product Type segmentation, Chronotherapy Drugs was predicted to show maximum market share in the year 2023

Based on Therapeutic Area segmentation, Oncology was the leading type in 2023

Based on End-user segmentation, Hospitals & Clinics was the leading type in 2023

based on Region, North America was the leading revenue generator in 2023

Chronotherapy Services Market- Segmentation Analysis:

The Global Chronotherapy Services Market is segmented based on Product Type, Therapeutic Area, End-user, and Region.

The market is divided into two categories based on Product Type: Chronotherapy System and Chronotherapy Drugs. In the Chronotherapy Services Market, the Chronotherapy Drugs segment is the most prominent and significant. This is primarily due to the increasing recognition of the importance of timing in drug delivery to enhance therapeutic efficacy. Chronotherapy drugs are specifically designed to work in sync with the body's natural circadian rhythms, improving treatment outcomes for conditions like asthma, hypertension, and cancer. The growing prevalence of chronic diseases and the demand for personalized medicine have driven the adoption of chronotherapy drugs, making them the dominant force in the market. Additionally, advancements in drug formulation and delivery systems have further bolstered their prominence.

The market is divided into five categories based on Therapeutic areas: Oncology, Neurology, Cardiovascular Diseases, Respiratory Diseases, and Others. In the Chronotherapy Services Market, the Oncology segment is the most prominent and significant. Cancer treatments often require precise timing to optimize drug efficacy and minimize side effects, making chronotherapy particularly valuable. Timing chemotherapy treatments to align with the body's circadian rhythms can enhance the effectiveness of drugs, improve patient outcomes, and reduce toxicity. With increasing cancer incidence globally and advancements in chronotherapy research, oncology has become the dominant therapeutic area, driving much of the growth in the chronotherapy services market. Further, the potential for improved patient compliance and treatment results further strengthens its prominence.

Chronotherapy Services Market- Geographical Insights

The North American regional landscape for the Chronotherapy Services market is characterized by a growing demand for personalized healthcare, especially in managing chronic conditions such as sleep disorders, depression, and hypertension. As the awareness of circadian rhythms and their impact on health increases, chronotherapy is gaining traction in both clinical and wellness settings. The U.S. leads the market, driven by advancements in medical technology, an aging population, and high healthcare expenditure. Canada is also showing growth, particularly in research and academic sectors. Key players in the region are focusing on developing innovative solutions, such as wearable devices and digital platforms, to optimize treatment timing. Government regulations, insurance coverage, and healthcare infrastructure play significant roles in shaping market dynamics. However, challenges like the need for clinical validation and patient adoption remain.

Chronotherapy Services Market- Competitive Landscape:

The competitive landscape of the chronotherapy services market is shaped by a mix of pharmaceutical giants, specialized biotechnology firms, and emerging players focusing on circadian rhythm-based therapies. Major pharmaceutical companies like Johnson & Johnson, Pfizer, and Novartis are investing in chronobiology research and developing treatments optimized for specific times of day, such as controlled-release medications or chronotherapy-focused drug delivery systems. Smaller, innovative companies like Circadian Therapeutics are advancing personalized chronotherapy models and offering tailored treatment solutions. The market is also supported by collaborations between healthcare providers, universities, and research institutes to explore new applications of chronobiology in conditions like cancer, mental health disorders, and sleep-related diseases. Competitive strategies include technological advancements in drug formulation, the use of wearable devices to monitor circadian rhythms, and the development of precision medicine to enhance patient outcomes. Growing awareness about the benefits of synchronizing treatment with biological clocks is expected to drive future competition.

Recent Developments:

In September 2023, Medtronic launched a pilot program to explore the benefits of chronotherapy for heart disease patients. Preliminary data suggests that aligning drug delivery with circadian rhythms could improve blood pressure management more effectively than traditional treatments.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CHRONOTHERAPY SERVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson
  • Novartis
  • Pfizer
  • Merck & Co.
  • Sanofi
  • Roche
  • GlaxoSmithKline
  • AbbVie
  • Bayer
  • Eli Lilly and Company
  • Amgen
  • AstraZeneca
  • Bristol-Myers Squibb
  • Gilead Sciences
  • Teva Pharmaceutical Industries
  • Medtronic
  • Zogenix
  • Circadian Therapeutics

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Chronotherapy System
  • Chronotherapy Drugs

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiovascular Diseases
  • Respiratory Diseases
  • Others

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Clinics
  • Homecare Settings
  • Others

GLOBAL CHRONOTHERAPY SERVICES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Chronotherapy Services Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Chronotherapy Services Market Snippet by Product Type
    • 2.1.2. Chronotherapy Services Market Snippet by Therapeutic Area
    • 2.1.3. Chronotherapy Services Market Snippet by End-user
    • 2.1.4. Chronotherapy Services Market Snippet by Country
    • 2.1.5. Chronotherapy Services Market Snippet by Region
  • 2.2. Competitive Insights

3. Chronotherapy Services Key Market Trends

  • 3.1. Chronotherapy Services Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Chronotherapy Services Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Chronotherapy Services Market Opportunities
  • 3.4. Chronotherapy Services Market Future Trends

4. Chronotherapy Services Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Chronotherapy Services Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Chronotherapy Services Market Landscape

  • 6.1. Chronotherapy Services Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Chronotherapy Services Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023&2032 (%)
    • 7.1.2. Chronotherapy System
    • 7.1.3. Chronotherapy Drugs

8. Chronotherapy Services Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2023&2032 (%)
    • 8.1.2. Oncology
    • 8.1.3. Neurology
    • 8.1.4. Cardiovascular Diseases
    • 8.1.5. Respiratory Diseases
    • 8.1.6. Others

9. Chronotherapy Services Market - By End-user

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-user, 2023&2032 (%)
    • 9.1.2. Hospitals & Clinics
    • 9.1.3. Homecare Settings
    • 9.1.4. Others

10. Chronotherapy Services Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023&2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Chronotherapy Services Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.7. The U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Chronotherapy Services Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Chronotherapy Services Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Chronotherapy Services Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Chronotherapy Services Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Chronotherapy Services Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson
    • 11.2.2. Novartis
    • 11.2.3. Pfizer
    • 11.2.4. Merck & Co.
    • 11.2.5. Sanofi
    • 11.2.6. Roche
    • 11.2.7. GlaxoSmithKline
    • 11.2.8. AbbVie
    • 11.2.9. Bayer
    • 11.2.10. Eli Lilly and Company
    • 11.2.11. Amgen
    • 11.2.12. AstraZeneca
    • 11.2.13. Bristol-Myers Squibb
    • 11.2.14. Gilead Sciences
    • 11.2.15. Teva Pharmaceutical Industries
    • 11.2.16. Medtronic
    • 11.2.17. Zogenix
    • 11.2.18. Circadian Therapeutics

12. 360 Degree AnalystView

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us